Holding(s) in Company

RNS Number : 5808Y

Dechra Pharmaceuticals PLC

04 September 2009

 



Form TR-1 with annex. FSA Version 2.1 updated April 2007

For filings with the FSA include the annex For filings with issuer exclude the annex

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:		DECHRA PHARMACEUTICALS PLC
2. Reason for notification (yes/no)
An acquisition or disposal of voting rights			Yes
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):______________
3. Full name of person(s) subject to notification obligation:	Artemis Investment Management Limited
4. Full name of shareholder(s) (if different from 3):	Artemis UK Smaller Companies Artemis Special Situations Barclays UK Smaller Companies Institutional Special Situations Pearson Prudential Staff Pension Scheme Akzo Nobel Pension Scheme Barclays UK Alpha L&G(Barclays) MM Alpha Fund L&G(Barclays) Series2 MM Alpha Fund Witan Investment Trust
5. Date of transaction (and date on which the threshold is crossed or reached if different):	02 September 2009
6. Date on which issuer notified:	03 September 2009
7. Threshold(s) that is/are crossed or reached:	5%

8: Notified Details
A: Voting rights attached to shares
Class/type of shares If possible use ISIN code	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
	Number of shares	Number of voting rights	Number of shares	Number of voting rights		Percentage of voting rights
				Direct	Indirect	Direct	Indirect
GB0009633180	2,578,649	2,578,649	3,613,481	3,613,481		5.51%

B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date	Exercise/ conversion period/date	No. of voting rights that may be acquired (if the instrument exercised/converted)	Percentage of voting rights

Total (A+B)
Number of voting rights	Percentage of voting rights
3,613,481	5.51%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Proxy Voting:
10. Name of proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:
14 Contact name:	Karen Paine
15. Contact telephone name:	0131 718 0414

For notes on how to complete form TR-1 please see the FSA website.   

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in shares

A: Identity of the persons or legal entity subject to the notification obligation
Full name  (including legal form of legal entities)	Artemis Investment Management Ltd
Contact address  (registered office for legal entities)	42 Melville Street Edinburgh, EH3 7HA
Phone number & email	0131 718 0414
Other useful information  (at least legal representative for legal persons)

B: Identity of the notifier, if applicable
Full name
Contact address
Phone number & email
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

 

END

 

 

HOLZGGGLDDDGLZM